The I-SPY clinical trial platform was designed to accelerate clinical development of neoadjuvant treatments for early-stage breast cancer. Although it is not without limitations, it provides a model for future response-adapted clinical trials.

中文翻译：

---

迈向肿瘤学反应适应试验


I-SPY 临床试验平台旨在加速早期乳腺癌新辅助治疗的临床开发。虽然并非没有限制，但它为未来的反应适应临床试验提供了一个模型。